Devlin Jodi
CIK 1992151 · Chief of Clinical Operations · last filed 2026-03-20
Devlin Jodi is a Chief of Clinical Operations who has filed 7 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing shows the insider sold $13.2K of TLSIW on Mar 20, 2026. Across all open-market trades the lifetime net is −$37.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $51.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$51.7K
1
7
-$37.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLSIW | Chief of Clinical Operations | 99,409 | $0.52 | $51.7K | -$37.8K | 7 | 2026-03-20 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-20 | TLSIW | Sell (S) | −3,207 | -$13.2K | EDGAR |
| 2025-11-25 | TLSIW | Grant (A) | +50,000 | $0 | EDGAR |
| 2025-05-21 | TLSIW | Mixed | +19,367 | $100.3K | EDGAR |
| 2025-02-19 | TLSIW | Grant (A) | +5,272 | $0 | EDGAR |
| 2025-01-29 | TLSIW | Grant (A) | +10,625 | $0 | EDGAR |
| 2024-02-14 | TLSIW | Grant (A) | +17,500 | $0 | EDGAR |
| 2023-08-31 | TLSIW | Grant (A) | — | $0 | EDGAR |